Return to content in this issue
Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23
Oda T, Sawada Y, Yamaguchi T, Ohmori S, Omoto D, Haruyama S, Yoshioka M, Okada E, Nakamura M
Department of Dermatology, University of Occupational and Environmental Health, Kitakyūshū, Japan
J Investig Allergol Clin Immunol 2017; Vol 27(1)
: 63-64
doi: 10.18176/jiaci.0116
Key words: Drug eruption, Psoriatic erythroderma, Terbinafine, IL-23